KONINKLIJKE PHILIPS (PHG) Stock: Buy, Sell, or Hold?
PHG - KONINKLIJKE PHILIPS N.V.
$24.59
-0.01 (-0.04%)
▼
5d:
-5.6%
30d:
-8.25%
90d:
-5.82%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When PHG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PHG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PHG shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.90
Based on 6.0% avg growth
INTRINSIC VALUE TODAY
$22.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHG is currently trading at $24.59, which is considered oversold relative to its 30-day fair value range of $25.76 to $27.42. The stock's valuation (Forward PE: 12.9) is in line with its historical norms (14.1). Remarkably, the market is currently pricing in an annual earnings decline of 2.9% over the next few years. This pessimistic expectation contrasts with the company's recent 61.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHG is showing sideways momentum. The price is currently testing key support at $24.48. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PHG scores 12/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.21 (+31.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHG is showing sideways momentum. The price is currently testing key support at $24.48. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PHG scores 12/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.21 (+31.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$25.76 -
$27.42
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (12/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.0% below Wall St target ($32.21)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$25.76 -
$27.42
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$24.49
Resistance Level
$26.97
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.92
Wall Street Target
$32.21
(+31.0%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
61.4%
Profit Margin
6.3%
Valuation Discount vs History
-2.9% cheaper
PE vs Historical
12.9 vs 14.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.9%
(market-implied from PE analysis)
1-Year Target
$23.88
(-3%)
2-Year Target
$23.18
(-6%)
3-Year Target
$22.51
(-9%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$24.57
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 8.0%)
$48.36
(+97%)
Base:
(SPY PE: 12.9, Growth: 8.0%)
$30.97
(+26%)
Bear:
(PE: 11.0, Growth: 8.0%)
$26.32
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 18.92 | Current EPS (TTM): $1.30
Bull Case
$39.63
(+61%)
Analyst growth 46.4%, PE expands to 20.8
Base Case
$36.02
(+47%)
Market implied 46.4%, PE stable at 18.9
Bear Case
$16.73
(-32%)
Severe decline -20.0%, PE contracts to 16.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.9 to 14.1
Stabilization Target:
$26.84
(+9.2%)
PE Expansion Potential:
+9.2%
Share & Embed Analysis
Last updated: September 12, 2026 9:37 AM ET
Data refreshes hourly during market hours. Next update: 10:37 AM
Data refreshes hourly during market hours. Next update: 10:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
